NCT03857841 - A Safety Study of IV Stem Cell-derived Extracellular Vesicles (UNEX-42) in Preterm Neonates at High Risk for BPD | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 9, 2019

Primary Completion Date

May 20, 2021

Study Completion Date

May 20, 2021

Conditions

Bronchopulmonary Dysplasia

Interventions

BIOLOGICAL

UNEX-42

UNEX-42 is a preparation of extracellular vesicles that are secreted from human bone marrow-derived mesenchymal stem cells suspended in phosphate-buffered saline.

BIOLOGICAL

Phosphate-buffered saline

Trial Locations (6)

39216

University of Mississippi Medical Center, Jackson

64108

Children's Mercy Hospital, Kansas City

80045

University of Colorado Hospital, Aurora

02115

Boston Children's Hospital, Boston

Brigham and Women's Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston